Cellectis SA (CLLS)
NASDAQ:CLLS

Cellectis SA (CLLS) Technical Analysis

864 Followers

Technical Sentiment

Overall Consensus
Buy
10Bullish
5Neutral
7Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Buy
7Bullish
0Neutral
5Bearish
Cellectis SA’s (CLLS) Moving Averages Convergence Divergence (MACD) indicator is -0.03, suggesting Cellectis SA is a Sell.
Cellectis SA’s (CLLS) 20-Day exponential moving average is 2.10, while Cellectis SA’s (CLLS) share price is $2.3, making it a Buy.
Cellectis SA’s (CLLS) 50-Day exponential moving average is 2.26, while Cellectis SA’s (CLLS) share price is $2.3, making it a Buy.

Cellectis SA (CLLS) Pivot Points

Jul 27, 2024, 05:19 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.95
1.98
2.01
2.04
2.07
2.10
2.13
Fibonacci
1.98
2.00
2.01
2.04
2.06
2.07
2.10
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Cellectis SA (CLLS) Moving Averages

Jul 27, 2024, 05:19 AM
Period
Simple
Exponential
MA5
2.11Buy
2.14Buy
MA10
2.11Buy
2.11Buy
MA20
2.04Buy
2.10Buy
MA50
2.33Sell
2.26Buy
MA100
2.50Sell
2.40Sell
MA200
2.57Sell
2.37Sell
Cellectis SA’s (CLLS) 10-Day exponential moving average is 2.11, while Cellectis SA’s (CLLS) share price is $2.3, making it a Buy.
Cellectis SA’s (CLLS) 100-Day exponential moving average is 2.40, while Cellectis SA’s (CLLS) share price is $2.3, making it a Sell.
Cellectis SA’s (CLLS) stock price is $2.3 and Cellectis SA’s (CLLS) 50-day simple moving average is 2.33, creating a Sell signal.
Cellectis SA’s (CLLS) stock price is $2.3 and Cellectis SA’s (CLLS) 100-day simple moving average is 2.50, creating a Sell signal.
Cellectis SA’s (CLLS) stock price is $2.3 and Cellectis SA’s (CLLS) 200-day simple moving average is 2.57, creating a Sell signal.

Cellectis SA (CLLS) Technical Indicators

Jul 27, 2024, 05:19 AM
Name
Value
Implied Action
RSI (14)
59.39
Neutral
STOCH (9,6)
38.26
Neutral
STOCHRSI (14)
63.95
Neutral
MACD (12,26)
-0.03
Sell
ADX (14)
20.68
Neutral
Williams %R
-22.03
Buy
CCI (14)
228.19
Sell
ATR (14)
0.13
-
Ultimate Oscillator
58.72
Neutral
ROC
13.86
Buy
Cellectis SA’s (CLLS) Relative Strength Index (RSI) is 59.39, creating a Neutral signal.
Cellectis SA’s (CLLS) Trend Strength Indicator (ADX) is 20.68, creating a Neutral signal.
Cellectis SA’s (CLLS) Commodity Channel Index (CCI) is 228.19, creating a Sell signal.
Cellectis SA’s (CLLS) Price Rate of Change (ROC) is 13.86, creating a Buy signal.

FAQ

Is CLLS a Buy, Hold, or Sell?
Based on CLLS’s technical indicators, CLLS is a Buy.
    What is CLLS’s RSI (14)?
    CLLS’s RSI (14) is 59.39, which suggests CLLS is a Neutral.
      What is CLLS’s MACD?
      CLLS’s MACD is -0.03, which suggests CLLS is a Sell.
        What is CLLS’s 5-day moving average?
        CLLS’s 5-day moving average is 2.11, which suggests CLLS is a Buy.
          What is CLLS’s 20-day moving average?
          CLLS 20-day moving average is 2.04, which suggests CLLS is a Buy.
            What is CLLS’s 50-day moving average?
            CLLS’s 50-day moving average is 2.33, which suggests CLLS is a Sell.
              What is CLLS’s 200-day moving average?
              CLLS’s 200-day moving average is 2.57, which suggests CLLS is a Sell.
                What is CLLS’s Williams % R (14)?
                CLLS’s Williams % R (14) is -22.03, which suggests CLLS is a Buy.
                  What is CLLS’s CCI (14)?
                  CLLS’s CCI (14) is 228.19, which suggests CLLS is a Sell.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis